Home / Sweden / Hansa Biopharma AB

Hansa Biopharma AB

Short position disclosed on August 11, 2026.

Follow

2.08% of the capital sold short
3 disclosing funds
428 disclosures on record
SE0002148817 ISIN code

Funds holding Hansa Biopharma AB Titelia

Evolution of the disclosed total

Open positions

History of disclosures

Other companies sold short in Sweden

• Samhällsbyggnadsbolaget i Norden AB 12.36% of the capital sold short
• Elekta AB (publ) 10.19% of the capital sold short
• JM AB 7.01% of the capital sold short
• Hemnet Group AB (publ) 6.08% of the capital sold short
• Bonesupport Holding AB 5.58% of the capital sold short
• Truecaller AB 5.43% of the capital sold short
• Embracer Group AB 5.25% of the capital sold short
• Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
• Tobii AB 4.34% of the capital sold short
• Dynavox Group AB 4.30% of the capital sold short
• RaySearch Laboratories AB (publ) 4.15% of the capital sold short
• Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short

Download as CSV